You are here

Hyphens Pharma prices IPO at S$0.26 a share to raise S$13.5m

The company made a net profit of S$6m in 2017, up 16% from 2016 as revenue rose 12% to S$113m

BT_20180512_MRHYPHENS12_3433952.jpg
Mr Lim says S$7 million of the listing proceeds will be used for business expansion. Another S$3 million will be used to consolidate operations in Singapore into one building with an automated packaging facility.

Singapore

HYPHENS Pharma International, which sells specialty pharmaceutical products, is seeking to raise S$13.5 million in net proceeds ahead of a listing on the Singapore Exchange's (SGX) Catalist board.

Hyphens is offering a total of 29.6 million...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes